• 18466 Citations
  • 69 Scopus h-Index
1976 …2019
If you made any changes in Pure, your changes will be visible here soon.

Research Output 1985 2019

Filter
Editorial
2019

Lung Cancer Worldwide

Adjei, A., Jun 1 2019, In : Journal of Thoracic Oncology. 14, 6, 1 p.

Research output: Contribution to journalEditorial

Lung Neoplasms

Progress in the Diagnosis and Treatment of Thoracic Malignancies Continues Unabated

Adjei, A., May 1 2019, In : Journal of Thoracic Oncology. 14, 5, 1 p.

Research output: Contribution to journalEditorial

Thorax
Neoplasms
2018

2017—A Banner Year for Thoracic Oncology

Adjei, A., Mar 1 2018, In : Journal of Thoracic Oncology. 13, 3, p. e33-e34

Research output: Contribution to journalEditorial

Thorax
2017
1 Citation (Scopus)

Avelumab: Another active immune checkpoint inhibitor in nonsmall cell lung cancer

Xie, H. & Adjei, A., Dec 1 2017, In : Translational Lung Cancer Research. 6, p. S41-S43

Research output: Contribution to journalEditorial

Non-Small Cell Lung Carcinoma
avelumab

Lung Cancer Awareness Month—A Lot of Progress, But More Work Needs to Be Done

Henningfield, M. F. & Adjei, A., Nov 1 2017, In : Journal of Thoracic Oncology. 12, 11, p. 1603-1605 3 p.

Research output: Contribution to journalEditorial

Lung Neoplasms
2 Citations (Scopus)

Predicting Clinical Outcomes Using Proteomics in Non–Small Cell Lung Cancer—The Past, Present, and Future

Soo, R. A. & Adjei, A., Apr 1 2017, In : Journal of Thoracic Oncology. 12, 4, p. 602-606 5 p.

Research output: Contribution to journalEditorial

Non-Small Cell Lung Carcinoma
Proteomics

The Journal of Thoracic Oncology Achieves a New Benchmark

Adjei, A., Sep 1 2017, In : Journal of Thoracic Oncology. 12, 9, 1 p.

Research output: Contribution to journalEditorial

Benchmarking
Thorax
2016
13 Citations (Scopus)

Anti-PD-1 Antibody Treatment and the Development of Acute Pulmonary Tuberculosis

Reungwetwattana, T. & Adjei, A., Jan 1 2016, In : Journal of Thoracic Oncology. 11, 12, p. 2048-2050 3 p.

Research output: Contribution to journalEditorial

Pulmonary Tuberculosis
Antibodies

The Journal of Thoracic Oncology in the next decade

Adjei, A., Jan 1 2016, In : Journal of Thoracic Oncology. 11, 1, 1 p.

Research output: Contribution to journalEditorial

Medical Oncology
Lung Neoplasms
Thorax
2015

A Milestone for the Journal of Thoracic Oncology

Adjei, A., Dec 1 2015, In : Journal of Thoracic Oncology. 10, 12, 1 p.

Research output: Contribution to journalEditorial

Thoracic Neoplasms
Medical Oncology
Thorax
1 Citation (Scopus)

Toward High-Precision Genomic Biomarkers: The Importance of Context

Tan, D. S. W. & Adjei, A., Sep 26 2015, In : Journal of Thoracic Oncology. 10, 9, p. 1237-1239 3 p.

Research output: Contribution to journalEditorial

Genomics
Phosphatidylinositol 3-Kinases
Biomarkers
2014

A note from the editor-in-chief on enhancements to the journal

Adjei, A., Jan 1 2014, In : Journal of Thoracic Oncology. 9, 9, 1 p.

Research output: Contribution to journalEditorial

Medical Societies
Lung Neoplasms
2013
1 Citation (Scopus)

Lung cancer - Celebrating progress and acknowledging challenges

Adjei, A., Nov 1 2013, In : Journal of Thoracic Oncology. 8, 11, p. 1350-1351 2 p.

Research output: Contribution to journalEditorial

Lung Neoplasms

Now that JTO has come of age, what's next?

Adjei, A., Jan 1 2013, In : Journal of Thoracic Oncology. 8, 1, 1 p.

Research output: Contribution to journalEditorial

2006
44 Citations (Scopus)

What is the right dose? The elusive optimal biologic dose in phase I clinical trials

Adjei, A., Sep 1 2006, In : Journal of Clinical Oncology. 24, 25, p. 4054-4055 2 p.

Research output: Contribution to journalEditorial

Drug Dose Response Relationship
Drug Administration Schedule
Indoles
Clinical Trials, Phase I
Protein Kinase Inhibitors
2004

Combining targeted agents in lung cancer

Belani, C. P. & Adjei, A., Nov 1 2004, In : Clinical Lung Cancer. 6, 3, 1 p.

Research output: Contribution to journalEditorial

Antineoplastic Combined Chemotherapy Protocols
Quinazolines
Sirolimus
Protein Kinase Inhibitors
Epidermal Growth Factor Receptor